127 related articles for article (PubMed ID: 33372800)
21. Tritium-labeled agonists as tools for studying adenosine A
Hinz S; Alnouri WM; Pleiss U; Müller CE
Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
[TBL] [Abstract][Full Text] [Related]
22. Identification of V6.51L as a selectivity hotspot in stereoselective A
Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H
Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993
[TBL] [Abstract][Full Text] [Related]
23. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
[TBL] [Abstract][Full Text] [Related]
24. A
Asano T; Noda Y; Tanaka KI; Yamakawa N; Wada M; Mashimo T; Fukunishi Y; Mizushima T; Takenaga M
Sci Rep; 2020 Feb; 10(1):3555. PubMed ID: 32103051
[TBL] [Abstract][Full Text] [Related]
25. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X
Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624
[TBL] [Abstract][Full Text] [Related]
26. The A
Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
28. Discovery of novel quinolinone adenosine A2B antagonists.
McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932
[TBL] [Abstract][Full Text] [Related]
29. Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist.
Vidal B; Nueda A; Esteve C; Domenech T; Benito S; Reinoso RF; Pont M; Calbet M; López R; Cadavid MI; Loza MI; Cárdenas A; Godessart N; Beleta J; Warrellow G; Ryder H
J Med Chem; 2007 May; 50(11):2732-6. PubMed ID: 17469811
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
[TBL] [Abstract][Full Text] [Related]
31. New A
Lambertucci C; Spinaci A; Buccioni M; Dal Ben D; Ngouadjeu Ngnintedem MA; Kachler S; Marucci G; Klotz KN; Volpini R
Bioorg Chem; 2019 Nov; 92():103183. PubMed ID: 31446240
[TBL] [Abstract][Full Text] [Related]
32. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
Hinz S; Lacher SK; Seibt BF; Müller CE
J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
[TBL] [Abstract][Full Text] [Related]
33. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
34. A
Basu S; Barawkar DA; Ramdas V; Waman Y; Patel M; Panmand A; Kumar S; Thorat S; Bonagiri R; Jadhav D; Mukhopadhyay P; Prasad V; Reddy BS; Goswami A; Chaturvedi S; Menon S; Quraishi A; Ghosh I; Dusange S; Paliwal S; Kulkarni A; Karande V; Thakre R; Bedse G; Rouduri S; Gundu J; Palle VP; Chugh A; Mookhtiar KA
Eur J Med Chem; 2017 Feb; 127():986-996. PubMed ID: 27842891
[TBL] [Abstract][Full Text] [Related]
35. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
[TBL] [Abstract][Full Text] [Related]
36. The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases.
Eisenstein A; Patterson S; Ravid K
J Cell Physiol; 2015 Dec; 230(12):2891-7. PubMed ID: 25975415
[TBL] [Abstract][Full Text] [Related]
37. 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2004 Dec; 47(26):6529-40. PubMed ID: 15588088
[TBL] [Abstract][Full Text] [Related]
38. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE
J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427
[TBL] [Abstract][Full Text] [Related]
39. Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Moro S; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2000 Dec; 43(25):4768-80. PubMed ID: 11123985
[TBL] [Abstract][Full Text] [Related]
40. 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.
Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Simorini F; Salerno S; Sergianni V; Tuccinardi T; Martinelli A; Cosimelli B; Greco G; Novellino E; Ciampi O; Trincavelli ML; Martini C
J Med Chem; 2007 Nov; 50(23):5676-84. PubMed ID: 17927167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
